相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study
Joachim Baech et al.
LEUKEMIA & LYMPHOMA (2020)
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
T. A. Eyre et al.
JOURNAL OF INTERNAL MEDICINE (2019)
R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients
Pernille Svendsen et al.
LEUKEMIA & LYMPHOMA (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS CARE & RESEARCH (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group
Frederic Peyrade et al.
LANCET HAEMATOLOGY (2017)
Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status
Elizabeth M. Curtis et al.
BONE (2016)
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2015)
Personal and Societal Burden of Osteoporotic Fractures
C. Fox et al.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2015)
Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study
J. Paccou et al.
ANNALS OF ONCOLOGY (2014)
Safety issues with bisphosphonate therapy for osteoporosis
Ernest Suresh et al.
RHEUMATOLOGY (2014)
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial
Jason R. Westin et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
David Cunningham et al.
LANCET (2013)
Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study
S. R. Majumdar et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
Frederic Peyrade et al.
LANCET ONCOLOGY (2011)
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Case finding for the management of osteoporosis with FRAX® -: assessment and intervention thresholds for the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures
Maria E. Cabanillas et al.
LEUKEMIA & LYMPHOMA (2007)
Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy
SH Kim et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures
A Oleksik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
